
- Telehealth Visits
- Insurance plan information

Jennifer Viner, NP, MS
Brain and Tumor Neurosurgery- Telehealth Visits
- Insurance plan information



Jennifer Viner, NP, MS
Brain and Tumor Neurosurgery- Telehealth Visits
- Insurance plan information
On this page
About me
Jennifer Viner is a nurse practitioner with more than a decade of experience who specializes in caring for patients with brain tumors including glioma, meningioma and brain metastasis. She works with patients throughout their hospitalization, performing comprehensive evaluations and coordinating follow-up treatments across different medical specialties.
In her research, Viner evaluates quality improvement efforts in health care systems as well as quality-of-life outcomes for patients. She is also involved in producing educational publications for patients and nurses-in-training.
Viner earned her master's degree in nursing from the UCSF School of Nursing and worked for more than a decade at UCSF before completing the doctor of nursing practice program. Prior to becoming part of UCSF's neuro-oncology team, she worked in neurosurgery and at the UCSF Bakar Precision Cancer Medicine Center. She is a certified adult nurse practitioner and a certified neuroscience registered nurse. She is an associate member of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.
Viner is an NPIII, a position UCSF awards to a select few nurses who have demonstrated excellence through advanced patient care, education, leadership and service.
Education & training
Board certification
- Adult Nurse Practitioner, American Nurses Credentialing Center
Degree
- MSN, UCSF School of Nursing
My expertise
Specialties
- Brain and Tumor Neurosurgery
Locations
My research
Publications
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.